Ye_2020_Proc.(Bayl.Univ.Med.Cent)_34_114

Reference

Title : Dipeptidyl-peptidase-like protein 6 encephalitis treated with immunotherapy - Ye_2020_Proc.(Bayl.Univ.Med.Cent)_34_114
Author(s) : Ye L , Schnegelsberg M , Obermann M
Ref : Proc (Bayl Univ Med Cent) , 34 :114 , 2020
Abstract :

This case describes a middle-aged man with anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis who exhibited the triad of memory loss, diarrhea, and tremor. The progression of his disease resembled neurodegenerative disease, and his first presentation at our department was 2 years after the first onset of symptoms. Antibodies against DPPX were positive in both serum and cerebrospinal fluid. No related tumor was found. The patient was initially treated with corticosteroid therapy and plasmapheresis. Despite moderate response to this treatment, corticosteroids were ceased because of adverse effects such as Cushing syndrome, deep vein thrombosis, and osteoporosis. After five cycles of treatment with rituximab, the patient experienced no further progression of neurologic symptoms and no adverse effects. The case adds to the understanding of the diagnosis, treatment, and potential prognosis of anti-DPPX encephalitis.

PubMedSearch : Ye_2020_Proc.(Bayl.Univ.Med.Cent)_34_114
PubMedID: 33456166
Gene_locus related to this paper: human-DPP6

Citations formats

Ye L, Schnegelsberg M, Obermann M (2020)
Dipeptidyl-peptidase-like protein 6 encephalitis treated with immunotherapy
Proc (Bayl Univ Med Cent) 34 :114

Ye L, Schnegelsberg M, Obermann M (2020)
Proc (Bayl Univ Med Cent) 34 :114